MedTrace Logo

Blood Transfusion by Boston MedFlight Registry

NCT04610814 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-09-01

No results posted yet for this study

Summary

The primary aim of this observational registry is to study the outcomes of patients with hemorrhagic shock transported by Boston MedFlight receiving blood products during transport.

Conditions

  • Hemorrhagic Shock

Sponsors & Collaborators

  • Boston MedFlight

    collaborator UNKNOWN

  • Boston Medical Center

    collaborator OTHER

  • Tufts Medical Center

    collaborator OTHER

  • Lahey Clinic

    collaborator OTHER

  • Beth Israel Deaconess Medical Center

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Susan R Wilcox, MD · Massachusetts General Hospital and Boston MedFlight

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04610814 on ClinicalTrials.gov